Pharma major Divi’s Laboratories Ltd on Saturday reported a 67.6% jump in its consolidated net profit to ₹538 crore for the Jan-March quarter of 2023-24 compared to the corresponding figure of ₹321 crore in the same period last year. Revenue for the quarter grew 18% to ₹2,303 crore from ₹1,951 crore in the same period a year ago.